HealthMEDS Inc., an over-the-counter drug maker, failed to provide FDA-requested records and did not respond to repeated FDA contacts.
What happened
FDA sent an electronic request for records and other information on February 1, 2021, to the contact email in HealthMEDS’s registration file for its over-the-counter drug products, including ProClean-Pure Atomizer Mist 5 mL. The company did not answer that request or FDA’s phone calls, and it also did not respond to a May 6, 2021 follow-up request sent by certified return-receipt mail. FDA said it therefore has no indication of the level of quality assurance for drugs registered as manufactured at the facility.
What FDA found
The company refused to permit access to or copying of records requested by FDA.
Section 301(e) of the FD&C Act (21 U.S.C. 331(e)); section 704(a)(4) (21 U.S.C. 374(a)(4))The company did not answer FDA’s February 1, 2021 electronic request for records.
Section 704(a)(4) of the FD&C Act (21 U.S.C. 374(a)(4))The company did not answer FDA’s May 6, 2021 follow-up request sent by certified mail.
Section 704(a)(4) of the FD&C Act (21 U.S.C. 374(a)(4))
What FDA wants
Respond within 48 hours to confirm or update registration and/or drug listing status and indicate whether you will respond to the records request. If you are no longer manufacturing drugs, delist all drugs using the last lot expiration date as the marketing end date and deregister the facility.
Who should pay attention
- OTC drug manufacturers and distributors
- brands selling hand sanitizers or other OTC drugs
- regulatory teams that manage FDA registration and drug listing
This is a summary. Read the original letter on fda.gov.